Jiang Min-yan, Cai Yan-na, Liang Cui-li, Peng Min-zhi, Sheng Hui-ying, Fan Li-ping, Lin Rui-zhu, Jiang Hua, Huang Yonglan, Liu Li
Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
Metab Brain Dis. 2015 Dec;30(6):1439-44. doi: 10.1007/s11011-015-9717-6. Epub 2015 Aug 12.
X-linked adrenoleukodystrophy is a common X-linked recessive peroxisomal disorder caused by the mutations in the ABCD1 gene. In this study, we analyzed 19 male patients and 9 female carriers with X-linked adrenoleukodystrophy in South China. By sequencing the ABCD1 gene, 13 different mutations were identified, including 7 novel mutations, and 6 known mutations, and 1 reported polymorphism. Mutation c.1180delG was demonstrated to be de novo mutation. 26.3 % (5/19) patients carried the deletion c.1415_16delAG, which may be the mutational hot spot in South China population. In addition, 73.7 % (14/19) patients were type of childhood cerebral adrenoleukodystrophy, 26.3 %(5/19) were in Addison only. Half of the childhood cerebral adrenoleukodystrophy patients had the adrenocortical insufficiency preceded the onset of neurological symptoms. Furthermore, 5 of 19 cases underwent hematopoietic stem cell transplantation. Our data showed that hematopoietic stem cell transplantation performed at an advanced stage of the cerebral X- linked adrenoleukodystrophy would accelerate the progression of the disease. Good clinical outcome achieved when hematopoietic stem cell transplantation performed at the very early stage of the disease.
X连锁肾上腺脑白质营养不良是一种常见的X连锁隐性过氧化物酶体疾病,由ABCD1基因突变引起。在本研究中,我们分析了中国南方19例男性X连锁肾上腺脑白质营养不良患者和9例女性携带者。通过对ABCD1基因进行测序,共鉴定出13种不同的突变,其中包括7种新突变、6种已知突变和1种已报道的多态性。突变c.1180delG被证明是新发突变。26.3%(5/19)的患者携带c.1415_16delAG缺失,这可能是中国南方人群的突变热点。此外,73.7%(14/19)的患者为儿童脑型肾上腺脑白质营养不良,26.3%(5/19)仅为艾迪生病型。半数儿童脑型肾上腺脑白质营养不良患者在神经症状出现之前就有肾上腺皮质功能不全。此外,19例患者中有5例接受了造血干细胞移植。我们的数据表明,在脑型X连锁肾上腺脑白质营养不良晚期进行造血干细胞移植会加速疾病进展。在疾病极早期进行造血干细胞移植可取得良好的临床疗效。